Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

Hepatology

Volumn 36, Issue 1, 2002, Pages 150-155

  Nair, Satheesh ^a   Mason, Andrew ^a   Eason, James ^a   Loss, George ^a   Perrillo, Robert P ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036288123     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.33713     Document Type: Article

References (37)

1. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
2. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis
3. Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance
4. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution
5. Obesity, hypertension, and the risk of kidney cancer in men
6. Abdominal obesity and breast cancer risk
7. Body mass index and colon cancer mortality in a large prospective study
8. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
9. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
10. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
11. Growth hormone, insulin-like growth factors and diabetes
12. Molecular mechanisms of insulin action
13. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987
14. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma
15. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: Sustained cell proliferation and biphasic activation of insulin-like growth factor II
16. Expression of insulinlike growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: Its relationship with hepatitis B virus antigen expression
17. Prevalence of and risk factors for hepatic steatosis in Northern Italy
18. Peroxismal beta-oxidation and steatohepatitis
19. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer
20. Oxy-radicals and cancer
21. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis
22. Hepatic hyperplasia in noncirrhotic fatty livers: Is obesity-related hepatic steatosis a premalignant condition?
23. Hormonal abnormalities in obesity
24. The epidemiology of serum sex hormones in postmenopausal women
25. Estrogen induction of hepatocellular carcinomas in Armenian hamsters
26. Serum testosterone: Estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients
27. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
28. A case-control study of diabetes mellitus and cancer risk
29. Diabetes mellitus and primary hepatocellular carcinoma
30. Medical history and primary liver cancer
31. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California
32. Diabetes mellitus and the risk of primary liver cancer
33. Excess risk of primary liver cancer in patients with diabetes mellitus
34. Role of diabetes mellitus in the etiology of hepatocellular carcinoma
35. Growth hormone, insulin-like growth factors and diabetes
36. Implications of the hyperinsulinaemiadiabetes-cancer link for preventive efforts
37. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients